Quantcast
Last updated on April 18, 2014 at 10:36 EDT

Latest parenteral nutrition Stories

2008-10-08 12:00:08

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today presented positive one-year data from a Phase 3-extension study of GATTEX(TM) (teduglutide), an investigational product for patients dependent upon parenteral nutrition due to short bowel syndrome (SBS). SBS is primarily caused by intestinal resection and the subsequent inability to maintain oral fluid, electrolyte, and nutrient balances. The results showed GATTEX was well tolerated out to one year and provided the ability to safely reduce...

2008-09-25 15:00:00

NPS Pharmaceuticals, Inc. Susan Mesco, 908-450-5516 smesco@npsp.com Logo: http://www.npsp.com NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today reported that three abstracts summarizing data from the company's Phase 3 studies of GATTEX(TM) (teduglutide) in patients with short bowel syndrome (SBS) were accepted for presentation at the American College of Gastroenterology (ACG) Annual Scientific Meeting and Postgraduate Course in Orlando, Florida, October 3-8, 2008, including an oral...

2008-09-11 18:00:09

NPS Pharmaceuticals (Nasdaq: NPSP) today reported that data from clinical studies of GATTEX(TM) (teduglutide) in intestinal failure associated with short bowel syndrome will be presented at upcoming medical meetings. At the 30th Congress of the European Society for Clinical Nutrition and Metabolism (ESPEN) taking place in Florence, Italy September 13-16, 2008 clinical data from a 24-week Phase 3 study of GATTEX for short bowel syndrome (SBS) patients who are dependent upon parenteral...

2008-09-04 09:00:09

By Fuentes-Orozco, Clotilde Cervantes-Guevara, Gabino; Mucino- Hernandez, Ivette; Lopez-Ortega, Alejandro; Ambriz-Gonzalez, Gabriela; Gutierrez-de-la-Rosa, Jose Luis; Gomez-Herrera, Efrain; Hermosillo-Sandoval, Jose Manuel; Gonzalez-Ojeda, Alejandro Background: The effect of parenteral GLN on recovery from severe acute pancreatitis has not been thoroughly investigated. The aims of this study were to determine whether parenteral GLN improves nutrition status and immune function, and to...

2008-09-04 03:00:07

By Koretz, Ronald L Sentence first, verdict afterward. -Queen of Hearts in Alice in Wonderland The Queen of Hearts presumed that the Knave was guilty of stealing her tarts, even though Alice had actually done this, and called for his head to be cut off. When the queen was informed that there had been no trial yet, she demanded that the sentence be executed; the trial verdict could follow. The practice of putting the cart before the horse actually dates back to antiquity. We have known...

2008-09-04 03:00:07

By Heyland, Daren K Dhaliwal, Rupinder; McClave, Steve The truth about the effectiveness of any given medical intervention is not a black or white answer. It is not a dichotomous outcome, either present or absent. Rather, it is represented by a mosaic of signals emerging across the basic and clinical studies of a particular issue so that, when systematically reviewed, the findings coalesce to give us a sense on a continuum, with one end anchored with "no(n) sense," to the other end anchored...

2008-09-04 03:00:07

By Atalay, Betul Gulsen Yagmur, Cahide; Nursal, Tarik Zafer; Atalay, Hakan; Noyan, Turgut The objective of this study is to examine the prevalence of malnutrition and evaluate the nutrition status and clinical outcome in hospitalized patients aged 65 years and older receiving enteral- parenteral nutrition. This retrospective study was carried out at Baskent University Hospital, Adana, Turkey. A total of 119 patients older than 65 years were recruited. Patients were classified into 3 groups:...

2008-09-04 03:00:07

By Kudsk, Kenneth A Pancreatitis is a nasty disease. It attacks young and old alike, often occurring without warning signs. Fortunately, most cases are rather mild and resolve spontaneously. However, a subpopulation of patients develops life-threatening disease, spending a month (usually longer) in the hospital with a large part of the stay spent in the intensive care unit (ICU). The disease poses several management problems for the clinician. First, the patients are hypermetabolic, rapidly...

2008-09-04 03:00:07

By Hardy, Gil Hardy, Ines J Bloodstream infections (BSIs) are among the most dangerous complications that can occur in the hospital. According to the recent Epic2: National Evidence-Based UK Guidelines, 3 in every 1000 patients acquire a BSI.1 The incidence of septicemia ranges up to 8% in patients receiving IV therapy, and one-third of BSIs are related to central venous lines used for parenteral nutrition (PN) or other intensive care therapies. Hospitalacquired infections (HAIs) affect 10%...

2008-09-04 03:00:07

By Thomson, Andrew Many trials and several meta-analyses have been devoted to comparing enteral with parenteral nutrition support. In this review, these studies are subjected to critical analysis with particular emphasis on their methodology and clinical relevance. Evidence is produced to suggest that the heterogeneous patient populations of the studies and the rigid approach taken to comparing different nutrition therapies inter alia render their conclusions highly questionable and of very...


Latest parenteral nutrition Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

More Articles (1 articles) »